First Time Loading...

Rosetta Genomics Ltd
OTC:ROSGQ

Watchlist Manager
Rosetta Genomics Ltd Logo
Rosetta Genomics Ltd
OTC:ROSGQ
Watchlist
Price: 0.0001 USD Market Closed
Updated: Apr 29, 2024

Rosetta Genomics Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Rosetta Genomics Ltd
Revenue Peer Comparison

Comparables:
CLGN
KMDA
URGN
ENTX
B
BONS

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Rosetta Genomics Ltd
OTC:ROSGQ
Revenue
$9.2m
CAGR 3-Years
184%
CAGR 5-Years
146%
CAGR 10-Years
N/A
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Revenue
$11m
CAGR 3-Years
21%
CAGR 5-Years
17%
CAGR 10-Years
N/A
Kamada Ltd
NASDAQ:KMDA
Revenue
$142.5m
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
7%
Urogen Pharma Ltd
NASDAQ:URGN
Revenue
$82.7m
CAGR 3-Years
91%
CAGR 5-Years
136%
CAGR 10-Years
N/A
Entera Bio Ltd
NASDAQ:ENTX
Revenue
$0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
Revenue
₪0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Rosetta Genomics Ltd's Revenue?
Revenue
9.2m USD

Based on the financial report for Dec 31, 2016, Rosetta Genomics Ltd's Revenue amounts to 9.2m USD.

What is Rosetta Genomics Ltd's Revenue growth rate?
Revenue CAGR 5Y
146%

Over the last year, the Revenue growth was 12%. The average annual Revenue growth rates for Rosetta Genomics Ltd have been 184% over the past three years , 146% over the past five years .